MEDICUS PHARMA LTD. Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount
MEDICUS PHARMA LTD. (MDCX) reported Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount of $42.87 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate · last filed 2026-03-25
- MEDICUS PHARMA LTD. effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2024 was $42.87K, a 90.19% decline from fiscal 2023.
- MEDICUS PHARMA LTD. effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2023 was $436.99K.
| Period end | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount 12 month |
|---|---|
| 2024-12-31 | $42.87K 10-K · filed 2026-03-25 |
| 2023-12-31 | $436.99K 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |